Breaking Finance News

BREAKING- Theragenics Up 7 Percent – Being Acquired by Juniper (TGX)

Share of Theragenics Corp (NYSE: TGX) are up more than 7 percent in pre-market trading after the company announced that it was being acquired by Juniper Investment company for $2.20 per share in cash–a 7.8 percent premium over Friday’s closing price.

Theragenics is a $59 million medical device company supplying disposable surgical products for cancer treatment primarily in the United States and Europe as well as general surgical supplies like sutures, and other wound closure products. The transaction is expected to close in the fourth quarter of this year with M. Christine Jacobs, the Company’s Chairman, Chief Executive Officer and President, stepping down once the deal is complete.

[stock-tools exchange="NYSE" symbol="TGX" image_height="230" image_width="350"]

Disclosure: At the time of this writing, the author had no position in the company mentioned.

New to Breaking Finance News? Read about our format here.

 

 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.